Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Psychopharmacology
|
July 12, 2008
A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia
Martin Sarter, Vicente Martinez, Rouba Kozak
Brain Research Reviews
|
March 15, 2006
More attention must be paid: the neurobiology of attentional effort
Martin Sarter, William J Gehring, Rouba Kozak
Cerebral Cortex (New York, N.Y. : 1991)
|
March 25, 2005
Augmented prefrontal acetylcholine release during challenged attentional performance
Rouba Kozak, John P Bruno, Martin Sarter
Neuron
|
October 9, 2007
Prefrontal acetylcholine release controls cue detection on multiple timescales
Vinay Parikh, Rouba Kozak, Vicente Martinez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 15, 2005
Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional task-performing rats
Subbu Apparsundaram, Vicente Martinez, Vinay Parikh, et al.
Biochemical and Biophysical Research Communications
|
February 21, 2006
Hypothalamic orexigenic peptides are overexpressed in young Long-Evans rats after early life exposure to fat-rich diets
Bernard Beck, Rouba Kozak, Kim M Moar, et al.
Behavioural Brain Research
|
July 22, 2004
Effects of changing reward on performance of the delayed spatial win-shift radial maze task in pedunculopontine tegmental nucleus lesioned rats
Claire L Taylor, Rouba Kozak, Mary P Latimer, et al.
Neurochemistry International
|
August 30, 2016
Nicotinic receptor subtypes differentially modulate glutamate release in the dorsal medial striatum
William M Howe, Damon A Young, George Bekheet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 6, 2018
Meta-analysis of amantadine efficacy for improving preclinical research reliability
Philip Stanley, Elsa Y Pioli, Rouba Kozak, et al.
CNS & Neurological Disorders Drug Targets
|
March 31, 2023
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson's Disease
Erwan Bezard, David Gray, Rouba Kozak, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Psychopharmacology
|
July 12, 2008
A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia
Martin Sarter, Vicente Martinez, Rouba Kozak
Brain Research Reviews
|
March 15, 2006
More attention must be paid: the neurobiology of attentional effort
Martin Sarter, William J Gehring, Rouba Kozak
Cerebral Cortex (New York, N.Y. : 1991)
|
March 25, 2005
Augmented prefrontal acetylcholine release during challenged attentional performance
Rouba Kozak, John P Bruno, Martin Sarter
Neuron
|
October 9, 2007
Prefrontal acetylcholine release controls cue detection on multiple timescales
Vinay Parikh, Rouba Kozak, Vicente Martinez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 15, 2005
Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional task-performing rats
Subbu Apparsundaram, Vicente Martinez, Vinay Parikh, et al.
Biochemical and Biophysical Research Communications
|
February 21, 2006
Hypothalamic orexigenic peptides are overexpressed in young Long-Evans rats after early life exposure to fat-rich diets
Bernard Beck, Rouba Kozak, Kim M Moar, et al.
Behavioural Brain Research
|
July 22, 2004
Effects of changing reward on performance of the delayed spatial win-shift radial maze task in pedunculopontine tegmental nucleus lesioned rats
Claire L Taylor, Rouba Kozak, Mary P Latimer, et al.
Neurochemistry International
|
August 30, 2016
Nicotinic receptor subtypes differentially modulate glutamate release in the dorsal medial striatum
William M Howe, Damon A Young, George Bekheet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 6, 2018
Meta-analysis of amantadine efficacy for improving preclinical research reliability
Philip Stanley, Elsa Y Pioli, Rouba Kozak, et al.
CNS & Neurological Disorders Drug Targets
|
March 31, 2023
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson's Disease
Erwan Bezard, David Gray, Rouba Kozak, et al.
Page
of 5